“Association of Ruxolitinib Cream Initiation With Continued Reduction in Use of Other Topical Treatments, Oral Corticosteroids, and Biologics for Atopic Dermatitis”. SKIN The Journal of Cutaneous Medicine 8, no. 6 (November 18, 2024): s455. Accessed May 26, 2026. https://skin.dermsquared.com/skin/article/view/3071.